Insulin resistance contributes to reducing the activity of lipoprotein lipase (LPL) and hepatic lipase, increasing plasmatic concentrations of atherogenic lipoproteins, such as small dense low-density lipoproteins (sdLDLs) and very low density lipoproteins (VLDLs) [55,64]. The gene discussed is LPL; the disease is Insulin resistance.